Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
American Journal of Hematology|November 23, 2013
Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patientsAxel Muendlein, Klaus Gasser, Elena Kinz, et al.Scientific Reports|March 25, 2021
Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patientsAxel Muendlein, Kathrin Geiger, Stella Gaenger, et al.Frontiers in Oncology|November 10, 2022
Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patientsAxel Muendlein, Luciano Severgnini, Thomas Decker, et al.Diabetes, Obesity & Metabolism|November 28, 2024
Three decades of glucose-lowering therapy in patients at high cardiovascular risk - A real-world analysisMagdalena Neyer, Johannes B Vogel, Pascal Elsner, et al.Journal of Clinical Medicine|October 14, 2023
Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery DiseaseAndreas Leiherer, Axel Muendlein, Christoph H Saely, et al.American Journal of Hematology|October 28, 2014
Occurrence of the JAK2 V617F mutation in patients with peripheral arterial diseaseAxel Muendlein, Elena Kinz, Klaus Gasser, et al.Cancer|July 9, 2004
Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian womenLukas A Hefler, Clemens B Tempfer, Christoph Grimm, et al.European Journal of Cancer (Oxford, England : 1990)|June 10, 2014
Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patientsAxel Muendlein, Michael Hubalek, Simone Geller-Rhomberg, et al.Journal of Cancer Research and Clinical Oncology|November 27, 2012
Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancerAxel Muendlein, Alois H Lang, Simone Geller-Rhomberg, et al.Journal of Cancer Research and Clinical Oncology|May 15, 2015
Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancerAxel Muendlein, Bettina H Rohde, Klaus Gasser, et al.Pageof 9